Biomedical Engineering Reference
In-Depth Information
Park E.K., Kim S.Y., Lee S.B., Lee Y.M. Folate-conjugated methoxy poly(ethylene glycol)/
poly(e-caprolactone) amphiphilic block copolymeric micelles for tumor targeted drug delivery.
J Control Release
109
:158-168 (2005).
Patapoff T.W., Overcashier D.E. The importance of freezing on lyophilization cycle development.
Biopharm
.
3
:16-21 (2002).
Peltonen L., Anitta J., Hyvönen S., Kajalainen M., Hirvonen J. Improved entrapment efficiency of
hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles.
AAPS
Pharm Sci Tech.
5
:1-6 (2004).
Perez C., Sanchez A., Putnam D., Ting D., Langer R., Alonso M.J. Poly(lactic acid)-poly(ethylene
glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
J Control Release
.
75
:211-224 (2001).
Petrelli F., Borgonovo K., Barni S. Targeted delivery for breast cancer therapy: the history of
nanoparticle-albumin-bound paclitaxel.
Expert Opin Pharmacother.
11
:1413-1432 (2010).
Qiu L.Y., Bae Y.H. Polymer architecture and drug delivery.
Pharm Res
.
23
(1):1-30 (2006).
Quintanar-Guerrero D., Ganem-Quintanar A., Allemann E., Fessi H., Doelker E. Influence of the
stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanopar-
ticles prepared by an emulsion-diffusion technique.
J Microencapsul
.
15
:107-119 (1998).
Quintanar-Guerrero D., Allémann E., Fessi H., Doelker E. Pseudolatex preparation using a novel
emulsion-diffusion process involving direct displacement of partially water-miscible solvents
by distillation.
Int. J. Pharm.
188
:155-164 (1999).
Rajaonarivony M., Vauthier C., Couarraze G., Puisieux F., Couvreur P. Development of a new
drug carrier made from alginate.
J. Pharm. Sci.
82
:912-918 (1993).
Rollot J., Couvreur P., Roblot-Treupel L., Puisieux F. Physicochemical and morphological char-
acterization of polyisobutylcyanoacrylate nanocapsules.
J Pharm Sci
.
75
:361-364 (1986).
Romberg B., Hennink W.E., Storm G. Sheddable coatings for long-circulating nanoparticles.
Pharm Res.
25
:55-71 (2008).
Sahoo S.K., Panyam J., Prabha S., Labhasetwar V. Residual polyvinyl alcohol associated with
poly (DL,-lactidecoglycolide) nanoparticles affects their physical properties and cellular
uptake.
J Control Release
.
82
:105-114 (2002).
Sani S.N., Das N.G., Das S.K. Effect of microfluidization parameters on the physical properties
of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
J Microencapsul.
26
:556-561 (2009).
Sarmento B., Ferreira D.C., Jorgensen L., van de Weert M. Probing insulin's secondary structure
after entrapment into alginate/chitosan nanoparticles.
Eur J Pharm Biopharm.
65
:10-17
(2007).
Schärtl W. Current directions in core-shell nanoparticle design.
Nanoscale
.
2
:829-843 (2010).
Schatz C., Domard A., Viton C., Pichot C., Delair T. Versatile and efficient formation of colloids
of biopolymer-based polyelectrolyte complexes.
Biomacromolecules
.
5
:1882-1892 (2004).
Shegokar R., Singh K.K., Müller R.H. Production & stability of stavudine solid lipid nanoparti-
cles-From lab to industrial scale.
Int J Pharm
. In Press 2010 Aug 18. [Epub ahead of print]
Sintzel M.B., Merklia A., Tabatabay C., Gurny R. Influence of irradiation sterilization on poly-
mers used as drug carriers : A review.
Drug Dev Ind Pharm.
23
:857-878 (1997).
Stainemesse S., Orecchioni A.M., Nakache E., Puisieux F., Fessi H. Formation and stabilization
of a biodegradable polymeric colloidal suspension of nanoparticles.
Colloid and Polym. Sci
.
273
:505-511 (1995).
Stork M., Tousain R.L., Wieringa J.A., Bosgra O.H. A MILP approach to the optimization of the
operation procedure of a fed-batch emulsification process in a stirred vessel.
Comp Chem Eng
.
27
:1681-1691 (2003).
Stuart M.A., Huck W.T., Genzer J., Müller M., Ober C., Stamm M., Sukhorukov G.B., Szleifer I.,
Tsukruk V.V., Urban M., Winnik F., Zauscher S., Luzinov I., Minko S. Emerging applications
of stimuli-responsive polymer materials.
Nat Mater.
9
:101-113 (2010).
Sun W., Mao S., Mei D., Kissel T. Self-assembled polyelectrolyte nanocomplexes between chito-
san derivatives and enoxaparin.
Eur J Pharm Biopharm.
69
:417-425 (2008).
Search WWH ::
Custom Search